Photo source: Redstate
As the economists note, instituting price caps skews the market and “leads to shortages, squeezes the cost bubble toward some other portion of the economy, and imposes a deadweight cost on society.”
In laymen’s terms: these price controls will restrict patient access to needed drugs and reduce drug makers’ ability to invest in the research and development of new medicines.
